Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

[Biology of metastases and molecular mechanisms of their formation].

Coussy F, Bonin F, Azorin P, Tariq Z, Driouch K.

Bull Cancer. 2019 Jan;106(1):24-36. doi: 10.1016/j.bulcan.2018.11.010. Epub 2018 Dec 14. Review. French.

PMID:
30554635
2.

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.

Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin JE, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E.

Oncogene. 2019 Feb;38(7):950-964. doi: 10.1038/s41388-018-0579-3. Epub 2018 Nov 26.

PMID:
30478447
3.

Distinct expression profiles and functions of Kindlins in breast cancer.

Azorin P, Bonin F, Moukachar A, Ponceau A, Vacher S, Bièche I, Marangoni E, Fuhrmann L, Vincent-Salomon A, Lidereau R, Driouch K.

J Exp Clin Cancer Res. 2018 Nov 26;37(1):281. doi: 10.1186/s13046-018-0955-4.

4.

VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX.

Bonin F, Taouis K, Azorin P, Petitalot A, Tariq Z, Nola S, Bouteille N, Tury S, Vacher S, Bièche I, Rais KA, Pierron G, Fuhrmann L, Vincent-Salomon A, Formstecher E, Camonis J, Lidereau R, Lallemand F, Driouch K.

BMC Biol. 2018 Oct 2;16(1):109. doi: 10.1186/s12915-018-0576-6.

5.

The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.

El-Hage P, Petitalot A, Monsoro-Burq AH, Maczkowiak F, Driouch K, Formstecher E, Camonis J, Sabbah M, Bièche I, Lidereau R, Lallemand F.

Mol Cancer Res. 2015 May;13(5):902-12. doi: 10.1158/1541-7786.MCR-14-0180. Epub 2015 Feb 12.

6.

The co-chaperone p23 promotes prostate cancer motility and metastasis.

Cano LQ, Lavery DN, Sin S, Spanjaard E, Brooke GN, Tilman JD, Abroaf A, Gaughan L, Robson CN, Heer R, Mauri F, de Rooij J, Driouch K, Bevan CL.

Mol Oncol. 2015 Jan;9(1):295-308. doi: 10.1016/j.molonc.2014.08.014. Epub 2014 Sep 6.

7.

Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome.

Bieche I, Pennaneach V, Driouch K, Vacher S, Zaremba T, Susini A, Lidereau R, Hall J.

Int J Cancer. 2013 Dec 15;133(12):2791-800. doi: 10.1002/ijc.28304. Epub 2013 Aug 9.

8.

Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness.

Dardenne E, Pierredon S, Driouch K, Gratadou L, Lacroix-Triki M, Espinoza MP, Zonta E, Germann S, Mortada H, Villemin JP, Dutertre M, Lidereau R, Vagner S, Auboeuf D.

Nat Struct Mol Biol. 2012 Nov;19(11):1139-46. doi: 10.1038/nsmb.2390. Epub 2012 Sep 30.

PMID:
23022728
9.

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.

Capulli M, Angelucci A, Driouch K, Garcia T, Clement-Lacroix P, Martella F, Ventura L, Bologna M, Flamini S, Moreschini O, Lidereau R, Ricevuto E, Muraca M, Teti A, Rucci N.

J Bone Miner Res. 2012 Nov;27(11):2387-98. doi: 10.1002/jbmr.1686.

10.

A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.

Sanz-Pamplona R, García-García J, Franco S, Messeguer X, Driouch K, Oliva B, Sierra A.

Mol Biosyst. 2012 Aug;8(8):2085-96. doi: 10.1039/c2mb25104c. Epub 2012 Jun 18.

PMID:
22710377
11.

A methodological approach to unravel organ-specific breast cancer metastasis.

Nola S, Sin S, Bonin F, Lidereau R, Driouch K.

J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):135-45. doi: 10.1007/s10911-012-9256-2. Epub 2012 May 25. Review.

PMID:
22628182
12.

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups.

Cizkova M, Susini A, Vacher S, Cizeron-Clairac G, Andrieu C, Driouch K, Fourme E, Lidereau R, Bièche I.

Breast Cancer Res. 2012 Feb 13;14(1):R28.

13.

Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.

Sin S, Bonin F, Petit V, Meseure D, Lallemand F, Bièche I, Bellahcène A, Castronovo V, de Wever O, Gespach C, Lidereau R, Driouch K.

J Natl Cancer Inst. 2011 Sep 7;103(17):1323-37. doi: 10.1093/jnci/djr290. Epub 2011 Aug 10.

PMID:
21832234
14.

Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors.

Sanz-Pamplona R, Aragüés R, Driouch K, Martín B, Oliva B, Gil M, Boluda S, Fernández PL, Martínez A, Moreno V, Acebes JJ, Lidereau R, Reyal F, Van de Vijver MJ, Sierra A.

Am J Pathol. 2011 Aug;179(2):564-79. doi: 10.1016/j.ajpath.2011.04.037. Epub 2011 Jun 25.

15.

Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy.

Bièche I, Vacher S, Lallemand F, Tozlu-Kara S, Bennani H, Beuzelin M, Driouch K, Rouleau E, Lerebours F, Ripoche H, Cizeron-Clairac G, Spyratos F, Lidereau R.

Mol Cancer. 2011 Feb 27;10:23. doi: 10.1186/1476-4598-10-23.

16.

Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases.

Dzięgiel P, Owczarek T, Plazuk E, Gomułkiewicz A, Majchrzak M, Podhorska-Okołów M, Driouch K, Lidereau R, Ugorski M.

Br J Cancer. 2010 Aug 10;103(4):524-31. doi: 10.1038/sj.bjc.6605750. Epub 2010 Jul 20.

17.

Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.

Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, Lidereau R, Driouch K, de la Grange P, Auboeuf D.

Cancer Res. 2010 May 1;70(9):3760-70. doi: 10.1158/0008-5472.CAN-09-3988. Epub 2010 Apr 20.

18.

Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.

Dutertre M, Lacroix-Triki M, Driouch K, de la Grange P, Gratadou L, Beck S, Millevoi S, Tazi J, Lidereau R, Vagner S, Auboeuf D.

Cancer Res. 2010 Feb 1;70(3):896-905. doi: 10.1158/0008-5472.CAN-09-2703. Epub 2010 Jan 26.

19.

Confounding effects in "a six-gene signature predicting breast cancer lung metastasis": reply.

Driouch K, Bonin F, Sin S, Clairac G, Lidereau R.

Cancer Res. 2009 Dec 15;69(24):9507-11. doi: 10.1158/0008-5472.CAN-09-2688.

20.

Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein.

Bouteille N, Driouch K, Hage PE, Sin S, Formstecher E, Camonis J, Lidereau R, Lallemand F.

Oncogene. 2009 Jul 16;28(28):2569-80. doi: 10.1038/onc.2009.120. Epub 2009 May 25.

PMID:
19465938
21.

A six-gene signature predicting breast cancer lung metastasis.

Landemaine T, Jackson A, Bellahcène A, Rucci N, Sin S, Abad BM, Sierra A, Boudinet A, Guinebretière JM, Ricevuto E, Noguès C, Briffod M, Bièche I, Cherel P, Garcia T, Castronovo V, Teti A, Lidereau R, Driouch K.

Cancer Res. 2008 Aug 1;68(15):6092-9. doi: 10.1158/0008-5472.CAN-08-0436.

22.

Functional pathways shared by liver and lung metastases: a mitochondrial chaperone machine is up-regulated in soft-tissue breast cancer metastasis.

Sanz R, Aragüés R, Stresing V, Martín B, Landemaine T, Oliva B, Driouch K, Lidereau R, Sierra A.

Clin Exp Metastasis. 2007;24(8):673-83. Epub 2007 Nov 16.

PMID:
18008173
23.

Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis.

Driouch K, Landemaine T, Sin S, Wang S, Lidereau R.

Clin Exp Metastasis. 2007;24(8):575-85. Epub 2007 Nov 1. Review.

PMID:
17973194
24.

Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.

Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.

Cancer Res. 2007 Sep 15;67(18):8742-51.

25.

Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.

Bièche I, Tozlu S, Girault I, Onody P, Driouch K, Vidaud M, Lidereau R.

Carcinogenesis. 2004 Mar;25(3):405-11. Epub 2003 Nov 21.

PMID:
14633660
26.

Prognostic value of ERBB family mRNA expression in breast carcinomas.

Bièche I, Onody P, Tozlu S, Driouch K, Vidaud M, Lidereau R.

Int J Cancer. 2003 Sep 20;106(5):758-65.

27.

Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.

Bièche I, Girault I, Sabourin JC, Tozlu S, Driouch K, Vidaud M, Lidereau R.

Br J Cancer. 2003 Mar 24;88(6):863-70.

28.

Evidence of chromosome regions and gene involvement in inflammatory breast cancer.

Lerebours F, Bertheau P, Bieche I, Driouch K, De The H, Hacene K, Espie M, Marty M, Lidereau R.

Int J Cancer. 2002 Dec 20;102(6):618-22.

29.

Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.

Driouch K, Prydz H, Monese R, Johansen H, Lidereau R, Frengen E.

Oncogene. 2002 Mar 14;21(12):1832-40.

30.

Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity.

Zborovskaya I, Gasparian A, Karseladze A, Elcheva I, Trofimova E, Driouch K, Trassard M, Tatosyan A, Lidereau R.

Int J Cancer. 1999 Sep 9;82(6):822-6.

31.

Location of several putative genes possibly involved in human breast cancer progression.

Driouch K, Briffod M, Bièche I, Champème MH, Lidereau R.

Cancer Res. 1998 May 15;58(10):2081-6.

32.

Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.

Wang Q, Driouch K, Courtois S, Champème MH, Bièche I, Treilleux I, Briffod M, Rimokh R, Magaud JP, Curmi P, Lidereau R, Puisieux A.

Oncogene. 1998 Feb 5;16(5):677-9.

33.

Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.

Driouch K, Dorion-Bonnet F, Briffod M, Champéme MH, Longy M, Lidereau R.

Genes Chromosomes Cancer. 1997 Jul;19(3):185-91.

PMID:
9219000
34.

Genetic alteration mapping on chromosome 7 in primary breast cancer.

Bièche I, Khodja A, Driouch K, Lidereau R.

Clin Cancer Res. 1997 Jun;3(6):1009-16.

35.

Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.

Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R.

Cancer Res. 1997 Mar 15;57(6):1058-62.

36.

Classical gene amplifications in human breast cancer are not associated with distant solid metastases.

Driouch K, Champème MH, Beuzelin M, Bièche I, Lidereau R.

Br J Cancer. 1997;76(6):784-7.

Supplemental Content

Loading ...
Support Center